323 related articles for article (PubMed ID: 27066792)
1. Non-functioning pituitary adenomas: growth and aggressiveness.
Øystese KA; Evang JA; Bollerslev J
Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
[TBL] [Abstract][Full Text] [Related]
2. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
[TBL] [Abstract][Full Text] [Related]
3. [Morphofunctional features of non-functioning pituitary adenomas].
Eremkina AK; Dzeranova LK; Pigarova EK; Mokrysheva NG; Dedov II
Arkh Patol; 2019; 81(1):71-78. PubMed ID: 30830109
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
[TBL] [Abstract][Full Text] [Related]
5. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
6. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
7. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
9. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
10. Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas.
Giuffrida G; D'Argenio V; Ferraù F; Lasorsa VA; Polito F; Aliquò F; Ragonese M; Cotta OR; Alessi Y; Oteri R; Di Maggio F; Asmundo A; Romeo PD; Spagnolo F; Pastore L; Angileri FF; Capasso M; Cannavò S; Aguennouz M
Front Endocrinol (Lausanne); 2022; 13():841118. PubMed ID: 35432200
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.
Ntali G; Wass JA
Pituitary; 2018 Apr; 21(2):111-118. PubMed ID: 29368293
[TBL] [Abstract][Full Text] [Related]
12. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
13. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
Iglesias P; Rodríguez Berrocal V; Díez JJ
Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age.
Yamaguchi-Okada M; Inoshita N; Nishioka H; Fukuhara N; Yamada S
J Neurosurg Pediatr; 2012 May; 9(5):511-6. PubMed ID: 22546029
[TBL] [Abstract][Full Text] [Related]
15. The need for adjunctive focused radiation therapy in pituitary adenomas.
Knosp E; Perneczky A; Kitz K; Grunert P; Wild A
Acta Neurochir Suppl; 1995; 63():81-4. PubMed ID: 7502734
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
[TBL] [Abstract][Full Text] [Related]
17. [Natural history study of postoperative residual non-functioning pituitary adenomas].
Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
[TBL] [Abstract][Full Text] [Related]
18. Management of non-functioning pituitary adenomas: surgery.
Penn DL; Burke WT; Laws ER
Pituitary; 2018 Apr; 21(2):145-153. PubMed ID: 29280026
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively.
Sam AH; Shah S; Saleh K; Joshi J; Roncaroli F; Robinson S; Cox J; Martin NM; Mendoza N; Meeran K; Mehta A; Dhillo WS
Clin Endocrinol (Oxf); 2015 Dec; 83(6):861-5. PubMed ID: 26201671
[TBL] [Abstract][Full Text] [Related]
20. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
